Table 4 HIV testing rate and HIV case finding during phase 1 and 3 by study site in outpatient and voluntary counseling and testing departments in eight health facilities, PITC study, Rwanda 2009-2010
Phase 1 | Phase 3 | Differences between phases 3 and 1 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study site | N | HIV testing rate n | HIV testing rate % | HIV + n | HIV+ % (% of testing rate) | HIV+ % (% of eligible) | N | HIV testing rate n | HIV testing rate % | HIV+ n | HIV+ % (% of testing rate) | HIV+ % (% of eligible) | Difference in testing rate | Difference in HIV case finding |
A | B | C = B/A | D | E = D/B | F = D/A | G | H | I = H/G | J | K = J/H | L = J/G | M = I - C | N = L - F | |
Rwaza | 2,863 | 1208 | 42.2 % | 14 | 1.2 % | 0.49 % | 3,987 | 1,588 | 39.8 % | 5 | 0.31 % | 0.13 % | -2.4 % | -0.36 % |
Kinyinya | 3,072 | 522 | 17.0 % | 30 | 5.7 % | 0.98 % | 3,878 | 701 | 18.1 % | 64 | 9.1 % | 1.65 % | 1.1 % | 0.67 % |
Ruhengeri | 3,829 | 195 | 5.1 % | 8 | 4.1 % | 0.21 % | 5,259 | 612 | 11.6 % | 11 | 1.8 % | 0.21 % | 6.5 % | 0.00 % |
Muhoza | 13,614 | 2919 | 21.4 % | 128 | 4.4 % | 0.94 % | 10,219 | 3,754 | 36.7 % | 142 | 3.8 % | 1.39 % | 15.3 % | 0.45 % |
Kibagabaga | 2,381 | 561 | 23.6 % | 72 | 12.8 % | 3.02 % | 3,623 | 398 | 11.0 % | 32 | 8.0 % | 0.88 % | -12.6 % | -2.14 % |
Kimironko | 5,155 | 374 | 7.3 % | 59 | 15.8 % | 1.14 % | 6,276 | 1389 | 22.1 % | 94 | 6.8 % | 1.50 % | 14.88 % | 0.35 % |
Total | 30,914 | 5,779 | 18.7 % | 311 | 5.4 % | 1.01 % | 33,242 | 8,442 | 25.4 % | 348 | 4.1 % | 1.05 % | 6.70 % | 0.04 % |
Gasiza (c) | 3,602 | 684 | 19.0 % | 16 | 2.3 % | 0.44 % | 3,154 | 665 | 21.1 % | 5 | 0.8 % | 0.16 % | 2.09 % | -0.29 % |
Kabuye (c) | 3,231 | 1554 | 48.1 % | 35 | 2.3 % | 1.08 % | 3,246 | 1714 | 52.8 % | 60 | 3.5 % | 1.85 % | 4.71 % | 0.77 % |
Total | 6,833 | 2,238 | 32.8 % | 51 | 2.3 % | 0.75 % | 6,400 | 2,379 | 37.2 % | 65 | 2.7 % | 1.02 % | 4.42 % | 0.27 % |